InvestorsHub Logo
Followers 85
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: Protector post# 152107

Friday, 12/13/2013 11:36:19 AM

Friday, December 13, 2013 11:36:19 AM

Post# of 346488
Great post! just reread that post and its becoming every so clear but not clear enough for my wife to agree to sell the house and move into a shack and just wait... wait... : )


wait for Big Pharma to wake up and accept "PS targeting" as the key to "immunotherapy"

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News